Ultra-Early Venous Thromboembolism (VTE) Prophylaxis in Spontaneous Intracerebral Hemorrhage (sICH)

IF 1.8 4区 医学 Q3 NEUROSCIENCES Journal of Stroke & Cerebrovascular Diseases Pub Date : 2021-02-01 Epub Date: 2020-11-27 DOI:10.1016/j.jstrokecerebrovasdis.2020.105476
Mohammed F. Kananeh MD , Mario J. Fonseca-Paricio MD , John W. Liang MD , Lindsay T. Sullivan MSN. ACNP , Kumud Sharma MD , Syed Omar Shah MD, MBA , Matthew D. Vibbert MD
{"title":"Ultra-Early Venous Thromboembolism (VTE) Prophylaxis in Spontaneous Intracerebral Hemorrhage (sICH)","authors":"Mohammed F. Kananeh MD ,&nbsp;Mario J. Fonseca-Paricio MD ,&nbsp;John W. Liang MD ,&nbsp;Lindsay T. Sullivan MSN. ACNP ,&nbsp;Kumud Sharma MD ,&nbsp;Syed Omar Shah MD, MBA ,&nbsp;Matthew D. Vibbert MD","doi":"10.1016/j.jstrokecerebrovasdis.2020.105476","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p><span>To determine if ultra-early (&lt;24 h) venous thromboembolism (VTE) prophylaxis was associated with </span>hematoma<span> growth in spontaneous intracerebral hemorrhage (ICH).</span></p></div><div><h3>Background</h3><p>Patients with ICH have a high risk of VTE. Pharmacological prophylaxis such as unfractionated heparin (UFH) have been demonstrated to reduce VTE. However, published datasets exclude patients with recent ICH out of concern for hematoma enlargement. American Heart/Stroke Association guidelines recommend UFH 1–4 days after hematoma stabilization while the European Stroke Organization has no recommendations on when to begin UFH. Our institutional practice is to obtain stability CT scans at 6 to 24 h and to begin UFH following documented clinical and radiologic stability. We examined the impact of this practice on hematoma expansion.</p></div><div><h3>Methods</h3><p>We performed a retrospective cohort analysis of consecutive ICH patients treated at a single tertiary academic referral center in the US. Demographic and clinical characteristics were abstracted. ICH volume was measured via 3D volumetrics for a CT head done on admission, follow-up stability, and prior to discharge. The primary outcome was analyzed as ≥3 mL hematoma enlargement. Secondary outcomes include hematoma expansion of ≥6mL and ≥ 33%, length of stay (LOS), discharge disposition and mortality.</p></div><div><h3>Results</h3><p>A total of 163 ICH patients were analyzed. There were 58 (35.6%) patients in the ultra-early UFH group and UFH was initiated on average at 13.8 h from initial scan. There were 105 (64.6%) patients in the standard group who initiated UFH at an average of 46.6 h. The primary outcome of hematoma enlargement ≥3 mL was observed in 2/58(3.4%) patients with ultra-early initiation of UFH and in 7/105(6.7%) in the standard group (<em>p</em>=0.49). Secondary outcomes were not significant including hematoma expansion in the ultra-early group ≥ 6 mL 3/58 (5.2%) and ≥33% 7/58 (12.1%) (<em>p</em>=0.91, 0.61, respectively) as well as mortality or LOS.</p></div><div><h3>Conclusion</h3><p>Venous thromboembolism prophylaxis started ultra-early (≤24 h) after ICH was not associated with hematoma expansion.</p></div>","PeriodicalId":54368,"journal":{"name":"Journal of Stroke & Cerebrovascular Diseases","volume":"30 2","pages":"Article 105476"},"PeriodicalIF":1.8000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jstrokecerebrovasdis.2020.105476","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stroke & Cerebrovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1052305720308946","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/11/27 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 5

Abstract

Objective

To determine if ultra-early (<24 h) venous thromboembolism (VTE) prophylaxis was associated with hematoma growth in spontaneous intracerebral hemorrhage (ICH).

Background

Patients with ICH have a high risk of VTE. Pharmacological prophylaxis such as unfractionated heparin (UFH) have been demonstrated to reduce VTE. However, published datasets exclude patients with recent ICH out of concern for hematoma enlargement. American Heart/Stroke Association guidelines recommend UFH 1–4 days after hematoma stabilization while the European Stroke Organization has no recommendations on when to begin UFH. Our institutional practice is to obtain stability CT scans at 6 to 24 h and to begin UFH following documented clinical and radiologic stability. We examined the impact of this practice on hematoma expansion.

Methods

We performed a retrospective cohort analysis of consecutive ICH patients treated at a single tertiary academic referral center in the US. Demographic and clinical characteristics were abstracted. ICH volume was measured via 3D volumetrics for a CT head done on admission, follow-up stability, and prior to discharge. The primary outcome was analyzed as ≥3 mL hematoma enlargement. Secondary outcomes include hematoma expansion of ≥6mL and ≥ 33%, length of stay (LOS), discharge disposition and mortality.

Results

A total of 163 ICH patients were analyzed. There were 58 (35.6%) patients in the ultra-early UFH group and UFH was initiated on average at 13.8 h from initial scan. There were 105 (64.6%) patients in the standard group who initiated UFH at an average of 46.6 h. The primary outcome of hematoma enlargement ≥3 mL was observed in 2/58(3.4%) patients with ultra-early initiation of UFH and in 7/105(6.7%) in the standard group (p=0.49). Secondary outcomes were not significant including hematoma expansion in the ultra-early group ≥ 6 mL 3/58 (5.2%) and ≥33% 7/58 (12.1%) (p=0.91, 0.61, respectively) as well as mortality or LOS.

Conclusion

Venous thromboembolism prophylaxis started ultra-early (≤24 h) after ICH was not associated with hematoma expansion.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
自发性脑出血患者的超早期静脉血栓栓塞(VTE)预防
目的探讨超早期(24 h)静脉血栓栓塞(VTE)预防是否与自发性脑出血(ICH)患者血肿生长有关。背景:脑出血患者发生静脉血栓栓塞的风险较高。药物预防如未分离肝素(UFH)已被证明可以降低静脉血栓栓塞。然而,由于担心血肿扩大,已发表的数据集排除了近期脑出血患者。美国心脏/中风协会指南建议在血肿稳定后1-4天进行UFH治疗,而欧洲中风组织对何时开始UFH治疗没有建议。我们的机构惯例是在6至24小时获得稳定的CT扫描,并在记录临床和放射学稳定后开始UFH。我们检查了这种做法对血肿扩张的影响。方法:我们对在美国某三级学术转诊中心连续治疗的脑出血患者进行回顾性队列分析。提取人口学和临床特征。通过入院时、随访稳定性和出院前对CT头部进行3D体积测量来测量脑出血体积。主要结局分析为血肿增大≥3ml。次要结局包括血肿扩张≥6mL和≥33%、住院时间(LOS)、出院处置和死亡率。结果共分析163例脑出血患者。超早期UFH组有58例(35.6%),平均在初次扫描后13.8 h开始出现UFH。标准组有105例(64.6%)患者在平均46.6 h开始UFH。2/58(3.4%)患者超早开始UFH,标准组有7/105(6.7%)患者超早开始UFH,主要结局血肿扩大≥3ml (p=0.49)。超早期组血肿扩大≥6 mL 3/58(5.2%)和≥33% 7/58 (12.1%)(p分别=0.91、0.61)、死亡率或LOS等次要结局无显著性差异。结论颅内出血后超早(≤24 h)开始静脉血栓栓塞预防与血肿扩张无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.00
自引率
4.00%
发文量
583
审稿时长
62 days
期刊介绍: The Journal of Stroke & Cerebrovascular Diseases publishes original papers on basic and clinical science related to the fields of stroke and cerebrovascular diseases. The Journal also features review articles, controversies, methods and technical notes, selected case reports and other original articles of special nature. Its editorial mission is to focus on prevention and repair of cerebrovascular disease. Clinical papers emphasize medical and surgical aspects of stroke, clinical trials and design, epidemiology, stroke care delivery systems and outcomes, imaging sciences and rehabilitation of stroke. The Journal will be of special interest to specialists involved in caring for patients with cerebrovascular disease, including neurologists, neurosurgeons and cardiologists.
期刊最新文献
Mechanical circulatory assist devices stroke subtype classification: a novel stroke classification system in patients with ventricular assist devices Metabolomic analysis of arterial blood near intracranial occlusions reveals biochemical signatures of acute ischemic stroke Prevalence and risk factors associated with anxiety and depression in patients with acute ischemic stroke who receive mechanical thrombectomy Toxic effects of herbal supplements on endothelial and vascular system among rural Thai patients: A multicenter cohort study Carotid revascularization and hemispheric white matter disease progression
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1